Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
CHOLMONDELEY PAULA H | 0001193675 | Nov-02-2023 | director |
DIAZ REINALDO M | 0001250086 | Nov-02-2023 | director |
ENRIGHT PATRICK G | 0001253886 | Nov-02-2023 | 10 percent owner |
Stampacchia Otello | 0001361712 | Nov-02-2023 | 10 percent owner |
Tammenoms Bakker Juliet | 0001431159 | Nov-02-2023 | 10 percent owner |
Altschuler Steven | 0001458116 | Nov-02-2023 | director |
Lundbeckfond Invest A/S | 0001591046 | Nov-02-2023 | 10 percent owner |
Paster Anne-Mari | 0001652863 | Nov-02-2023 | 10 percent owner |
Nessi Claudio | 0001722050 | Nov-02-2023 | 10 percent owner |
Agger Mette Kirstine | 0001722234 | Nov-02-2023 | director |
Omega Fund VI, L.P. | 0001757917 | Nov-02-2023 | 10 percent owner |
Longitude Venture Partners IV, L.P. | 0001787456 | Nov-02-2023 | 10 percent owner |
Omega Fund VI GP Manager, Ltd. | 0001826584 | Nov-02-2023 | 10 percent owner |
Omega Fund VI GP, L.P. | 0001826592 | Nov-02-2023 | 10 percent owner |
Longitude Capital Partners IV, LLC | 0001829169 | Nov-02-2023 | 10 percent owner |
COOPERSTONE BRENDA | 0001931514 | Nov-02-2023 | director |
Adler Eric | 0001994972 | Nov-02-2023 | officer: Chief Scientific Officer |
Davitian Bernard | 0001994973 | Nov-02-2023 | director |
McCormac Paul | 0001994981 | Nov-02-2023 | officer: Chief Technical Officer |
Robertson Jenny | 0001995009 | Nov-02-2023 | officer: Chief Legal and Admin. Officer |
Townsend Richard Nolan | 0001995218 | Nov-02-2023 | director, officer: Chief Executive Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Lexeo Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950170-24-046200 (33 Act) Size: 424 KB |
Apr-22-2024 | 24859570 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950170-24-046199 (33 Act) Size: 50 KB |
Apr-22-2024 | 24859564 |
8-K | Document | Current report filing Acc-no: 0000950170-24-046197 (34 Act) Size: 540 KB |
Apr-22-2024 | 24859562 |
8-K | Document | Current report filing Acc-no: 0000950123-24-003417 (34 Act) Size: 150 KB |
Apr-22-2024 | 24859555 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950170-24-044601 (33 Act) Size: 402 KB |
Apr-16-2024 | 24846113 |
8-K | Document | Current report filing Acc-no: 0000950170-24-044598 (34 Act) Size: 452 KB |
Apr-16-2024 | 24846108 |
EFFECT | Document | Acc-no: 9999999995-24-000964 (33 Act) Size: 1 KB | Apr-12-2024 | 24843019 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-24-094850 (33 Act) Size: 5827 KB |
Apr-12-2024 | 24842251 |
S-1 | Document | General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001193125-24-090233 (33 Act) Size: 16151 KB |
Apr-09-2024 | 24831181 |
8-K | Document | Current report filing Acc-no: 0000950170-24-029249 (34 Act) Size: 1063 KB |
Mar-11-2024 | 24738112 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000950170-24-029222 (33 Act) Size: 400 KB |
Mar-11-2024 | 24738051 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-028941 (34 Act) Size: 13578 KB |
Mar-11-2024 | 24736761 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023927 (34 Act) Size: 134 KB |
Feb-14-2024 | 24639964 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-036405 (34 Act) Size: 134 KB |
Feb-14-2024 | 24639562 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023824 (34 Act) Size: 64 KB |
Feb-14-2024 | 24639285 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001274173-24-000061 (34 Act) Size: 10 KB |
Feb-14-2024 | 24635666 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-24-001520 (34 Act) Size: 64 KB |
Feb-14-2024 | 24631844 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-033858 (34 Act) Size: 87 KB |
Feb-13-2024 | 24626874 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001209191-24-002931 ( Act) Size: 10 KB |
Feb-06-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-002930 ( Act) Size: 5 KB |
Feb-06-2024 |
Recent 20 filings. View all Lexeo Therapeutics, Inc. filings
It's being easier working on the website. And I recommend, it's a great website
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by